Table 5.
Cohort B: summary of study characteristics
|
Characteristics |
Number |
(%) |
|
|---|---|---|---|
| n = 43 | |||
|
Funding |
|
|
|
| Not for profit |
10 |
(23.3) |
|
| For profit |
11 |
(25.6) |
|
| Mixed (not for profit and for profit) |
2 |
(4.7) |
|
| Not reported |
20 |
(45.6) |
|
| Unclear |
0 |
(0.0) |
|
|
Type of Wound |
|
|
|
| Leg ulcer |
24 |
(55.8) |
|
| Diabetic foot ulcer |
13 |
(30.2) |
|
| Pressure ulcer |
5 |
(11.6) |
|
| Mixed ulcers |
1 |
(2.3) |
|
|
Intervention |
|
|
|
| Device |
28 |
(65.1) |
|
| Drug |
12 |
(27.9) |
|
| Surgery |
1 |
(2.3) |
|
| Care management |
2 |
(4.7) |
|
|
Comparator (note, in trials >2 arms there is >1 comparator) |
|
n = 51 |
|
| Placebo |
19 |
(37.3) |
|
| Usual care |
8 |
(15.7) |
|
| Device |
17 |
(33.3) |
|
| Drug |
4 |
(7.8) |
|
| Surgery |
2 |
(3.9) |
|
| Care management |
1 |
(2.0) |
|
|
Duration of follow up |
Median |
(IQR) |
Range |
| Weeks | 8 | (4–13) | 2–104 |